Crosstree

Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstrees narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors,...

M&a,divestiture,recapitalization,buyout,equity,merger,acquisition,life sciences,health sciences,pharma services,pharma technology,healthcare it,digital health,and laboratory services

Crosstree operates in the Investment banking industry.

Crosstree's revenue is 11m - 100m

Crosstree has 51 - 200 employees.